Sherwin-Williams Valuation
Is SHW * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SHW * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SHW * (MX$5401) is trading above our estimate of fair value (MX$3757.93)
Significantly Below Fair Value: SHW * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SHW *?
Other financial metrics that can be useful for relative valuation.
What is SHW *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$80.91b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 4.1x |
Enterprise Value/EBITDA | 21.9x |
PEG Ratio | 4.5x |
Price to Earnings Ratio vs Peers
How does SHW *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 33.2x | ||
GMEXICO B Grupo México. de | 14.5x | 6.0% | Mex$812.2b |
ECL Ecolab | 42.9x | 12.3% | US$66.5b |
4063 Shin-Etsu Chemical | 22.2x | 10.8% | JP¥11.5t |
CEMEX CPO CEMEX. de | 53.2x | 34.2% | Mex$191.1b |
SHW * Sherwin-Williams | 33.5x | 7.4% | Mex$80.9b |
Price-To-Earnings vs Peers: SHW * is expensive based on its Price-To-Earnings Ratio (33.5x) compared to the peer average (33.2x).
Price to Earnings Ratio vs Industry
How does SHW *'s PE Ratio compare vs other companies in the Global Chemicals Industry?
Price-To-Earnings vs Industry: SHW * is expensive based on its Price-To-Earnings Ratio (33.5x) compared to the Global Chemicals industry average (22.3x).
Price to Earnings Ratio vs Fair Ratio
What is SHW *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 33.5x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SHW *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$5,401.00 | Mex$5,732.57 +6.1% | 12.4% | Mex$6,760.84 | Mex$3,701.56 | n/a | 24 |
May ’25 | Mex$5,150.00 | Mex$5,775.68 +12.1% | 12.1% | Mex$6,829.64 | Mex$3,739.23 | n/a | 25 |
Apr ’25 | n/a | Mex$5,530.86 0% | 13.8% | Mex$6,682.93 | Mex$3,557.58 | n/a | 24 |
Mar ’25 | Mex$5,634.00 | Mex$5,500.27 -2.4% | 11.3% | Mex$6,314.64 | Mex$3,652.25 | n/a | 24 |
Feb ’25 | Mex$5,280.50 | Mex$5,464.25 +3.5% | 11.1% | Mex$6,200.10 | Mex$3,685.62 | n/a | 23 |
Jan ’25 | Mex$5,212.90 | Mex$5,097.13 -2.2% | 11.6% | Mex$6,131.63 | Mex$3,644.91 | n/a | 24 |
Dec ’24 | Mex$4,737.90 | Mex$4,964.17 +4.8% | 9.9% | Mex$5,713.49 | Mex$3,705.11 | n/a | 24 |
Nov ’24 | Mex$4,322.35 | Mex$5,047.04 +16.8% | 9.7% | Mex$5,878.06 | Mex$3,811.83 | n/a | 24 |
Oct ’24 | Mex$4,500.00 | Mex$5,190.01 +15.3% | 8.4% | Mex$5,752.23 | Mex$3,677.94 | n/a | 24 |
Sep ’24 | Mex$4,676.25 | Mex$4,956.79 +6.0% | 9.3% | Mex$5,529.22 | Mex$3,535.35 | n/a | 25 |
Aug ’24 | Mex$4,730.00 | Mex$4,969.97 +5.1% | 9.4% | Mex$5,564.23 | Mex$3,557.73 | n/a | 25 |
Jul ’24 | Mex$4,469.62 | Mex$4,412.72 -1.3% | 8.9% | Mex$4,964.66 | Mex$3,441.02 | n/a | 25 |
Jun ’24 | Mex$4,164.90 | Mex$4,513.49 +8.4% | 8.7% | Mex$5,129.64 | Mex$3,555.37 | n/a | 24 |
May ’24 | Mex$4,124.00 | Mex$4,562.08 +10.6% | 8.9% | Mex$5,199.29 | Mex$3,603.65 | Mex$5,150.00 | 24 |
Apr ’24 | Mex$3,805.20 | Mex$4,498.09 +18.2% | 9.9% | Mex$5,226.50 | Mex$3,604.48 | n/a | 24 |
Mar ’24 | Mex$3,969.52 | Mex$4,566.46 +15.0% | 9.9% | Mex$5,329.07 | Mex$3,675.22 | Mex$5,634.00 | 26 |
Feb ’24 | Mex$4,466.00 | Mex$4,698.31 +5.2% | 10.2% | Mex$5,648.85 | Mex$3,765.90 | Mex$5,280.50 | 27 |
Jan ’24 | Mex$4,660.95 | Mex$5,122.27 +9.9% | 11.1% | Mex$5,868.78 | Mex$3,912.52 | Mex$5,212.90 | 25 |
Dec ’23 | Mex$4,594.00 | Mex$4,964.91 +8.1% | 10.9% | Mex$5,793.81 | Mex$3,862.54 | Mex$4,737.90 | 25 |
Nov ’23 | Mex$4,375.70 | Mex$5,062.18 +15.7% | 10.9% | Mex$5,944.32 | Mex$3,962.88 | Mex$4,322.35 | 25 |
Oct ’23 | n/a | Mex$5,362.97 0% | 10.8% | Mex$6,545.01 | Mex$4,027.70 | Mex$4,500.00 | 23 |
Sep ’23 | n/a | Mex$5,396.89 0% | 10.0% | Mex$6,469.03 | Mex$3,980.94 | Mex$4,676.25 | 22 |
Aug ’23 | Mex$4,990.00 | Mex$5,561.15 +11.4% | 11.2% | Mex$6,927.13 | Mex$4,074.78 | Mex$4,730.00 | 22 |
Jul ’23 | Mex$4,586.85 | Mex$5,951.01 +29.7% | 11.6% | Mex$6,977.18 | Mex$3,927.16 | Mex$4,469.62 | 21 |
Jun ’23 | Mex$5,242.00 | Mex$5,902.61 +12.6% | 11.3% | Mex$6,888.56 | Mex$3,877.28 | Mex$4,164.90 | 21 |
May ’23 | Mex$5,747.00 | Mex$6,226.87 +8.3% | 10.7% | Mex$7,151.45 | Mex$4,025.24 | Mex$4,124.00 | 20 |
Analyst Forecast: Target price is less than 20% higher than the current share price.